Sales at Quest Diagnostics's base business excluding COVID-19 products rose 10% from a year earlier to $2.21 billion. Healthcare giant Abbott Laboratories (ABT.N) and hospital operator HCA Healthcare Inc (HCA.N) last week sounded optimistic about demand for medical device procedures, routine diagnostic testing and consumer-based health products, as cases of COVID-19 infection decline. April 27 (Reuters) - Quest Diagnostics Inc (DGX.N) posted first-quarter profit ahead of Wall Street estimates on Thursday as its base business helped offset a fall in COVID-19 test kits sales.ĭemand for routine diagnostic tests has picked up as an increasing number of people return to the healthcare system for routine care after delaying care during the pandemic.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |